EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Paul Modi
Joseph Rahamim
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Modi, P.
Right arrow Articles by Rahamim, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Modi, P.
Right arrow Articles by Rahamim, J.
Related Collections
Right arrow Esophagus - cancer

Eur J Cardiothorac Surg 2005;28:167-168
© 2005 Elsevier Science NL


How-to-do-it

Fibrin sealant treatment of splenic injuries during oesophagectomy

Paul Modi * , Joseph Rahamim

Department of Cardiothoracic Surgery, Derriford Hospital, Plymouth PL6 8DH, UK

Received 12 December 2004; received in revised form 2 February 2005; accepted 7 February 2005.

* Corresponding author. Tel./fax: +44 1752 792327. (Email: paulmodi{at}doctors.org.uk).


    Abstract
 Top
 Abstract
 1. Introduction
 2. Technique
 3. Discussion
 References
 
The incidence of ‘accidental’ splenectomy during oesophagectomy varies from 4 to 42% and leads to an increase in sepsis, anastomotic leakage and mortality. Therefore, preservation of the spleen should be the aim of treatment whenever splenic injury occurs. We describe the use of fibrin glue delivered as a thin film by a spray applicator for rapid and definitive haemostasis of grades 1 and 2 splenic injuries in patients undergoing oesophagectomy.

Key Words: Spleen • Oesophagectomy • Iatrogenic • Fibrin tissue adhesive


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Technique
 3. Discussion
 References
 
Splenectomy due to accidental operative trauma, caused by excessive traction on the splenic ligaments or misplacement of retractors, accounts for 10–26% of all splenectomies [1]. The incidence of ‘accidental’ splenectomy due to operative trauma during oesophagectomy varies greatly from 4 to 42% in published series [2–4]. The role of the spleen in modulating immune function is well recognised and the addition of splenectomy to oesophagectomy greatly increases the risk of pneumonia, sepsis, anastomotic leakage and mortality (35.7 vs 8.1%) [3]. Preservation of the spleen is therefore of paramount importance and an attempt at local control should be the first step. Conservative measures such as compression, fulguration, suture, oxidised cellulose or absorbable gelatin sponges are often unsuccessful. We describe the use of fibrin glue for rapid and definitive haemostasis of grades 1 and 2 (Organ Injury Scale Committee, 1989) splenic injuries sustained during oesophagectomy.


    2. Technique
 Top
 Abstract
 1. Introduction
 2. Technique
 3. Discussion
 References
 
Of 50 patients who underwent Ivor Lewis gastro-oesophagectomy at our institution over the last 18 months, 10 (20%) inadvertently experienced grade 1 or 2 splenic injury during mobilisation of the gastric fundus and ligation of the short gastric arteries. All injuries were recognised at the time they occurred and temporary haemostasis was achieved with fibrillar cellulose and compression until mobilisation of the fundus was completed. In all cases, the fibrin sealant (Tisseel, Baxter Healthcare Corp., Deerfield, IL 60015, USA) was reconstituted and warmed in accordance with the manufacturer's guidelines and applied to the splenic laceration with a double-barrelled syringe with a spray applicator from a distance of about 15cm to create a thin fibrin film (Fig. 1 ). Rapid haemostasis was achieved in all cases with no recurrent bleeding.



View larger version (60K):
[in this window]
[in a new window]
 
Fig. 1. Grade 1 splenic injury (arrowed) before (A) and after (B) application of fibrin glue.

 

    3. Discussion
 Top
 Abstract
 1. Introduction
 2. Technique
 3. Discussion
 References
 
Fibrin sealant, also called fibrin glue or fibrin tissue adhesive, is a biological haemostatic agent that coagulates and seals upon application and includes a range of products designed to simulate the final stage of the coagulation cascade. The fibrinogen and thrombin components, which are packaged separately, form loosely packed fibrin monomers when mixed together in equal quantities which then polymerise under the influence of factor XIII and calcium chloride to form stable fibrin protofibrils. Through a process of side-to-side aggregation, these protofibrils form enmeshed fibrin filaments of sufficient strength to bridge the defect between wound edges. Aprotinin, a bovine serine protease and kallikrein inhibitor, is also added and increases the resistance to fibrinolysis and promotes clot longevity [5]. To prevent premature activation, the fibrinogen and thrombin elements are separated in a double-barrelled syringe that can be connected to a pressurised gas source (air or nitrogen at 1.5–2bar). The gas flow dries the surface to which the glue is to be applied and atomises/mixes the 2 components allowing a thin fibrin film to be sprayed on to a large surface area. Fibrin glue can also be delivered as a broad stream or injected into the parenchyma of solid organs.

Fibrin glue has been successfully used in patients with acquired and congenital bleeding disorders, and in procedures with a high risk of operative bleeding. It has also been used for blunt and penetrating abdominal trauma with a reported 86% splenic salvage rate, compared with 50% in historic controls [6,7], and in urological work during open and laparoscopic partial nephrectomy [5]. However, its use has not been previously reported during elective oesophagectomy and it would be expected to decrease the need for splenectomy and blood transfusion.

In summary, topical application of fibrin sealant can rapidly achieve definitive haemostasis of grades 1 and 2 splenic injuries in patients undergoing oesophagectomy. The advantages of avoiding splenectomy in this group of patients are so great that it is important all oesophageal surgeons are aware of its use.


    References
 Top
 Abstract
 1. Introduction
 2. Technique
 3. Discussion
 References
 

  1. Coon WW. Iatrogenic splenic injuries. Am J Surg 1990;159:585-592.[Medline]
  2. Hambraeus GM, Mercke CE. Consequence of splenectomy in oesophageal carcinoma. Lancet 1979;17(1(8116)):621.[CrossRef]
  3. Kyriazanos ID, Tachibana M, Yoshimura H, Kinugasa S, Dhar DK, Nagasue N. Impact of splenectomy on the early outcome after oesophagectomy for squamous cell carcinoma of the oesophagus. Eur J Surg Oncol 2002;28:113-119.[Medline]
  4. Hankins JR, Miller JE, Attar S, McLaughlin JS. Transhiatal esophagectomy for carcinoma of the oesophagus: experience with 26 patients. Ann Thorac Surg 1987;44(2):123-127.[Abstract]
  5. Canby-Hagino ED, Morey AF, Jatoi I, Perahia B, Bishoff JT. Fibrin sealant treatment of splenic injury during open and laparoscopic left radical nephrectomy. J Urol 2000;164(6):2004-2005.[CrossRef][Medline]
  6. Kram HB, del Junco T, Clark SR, Ocampo HP, Shoemaker WC. Techniques of splenic preservation using fibrin glue. J Trauma 1990;30(1):97-101.[Medline]
  7. Uranus S, Mischinger H-J, Pfeifer J, Kronberger L, Rabl H, Werkgartner G, Steindorfer P, Kraft-Kirz J. Hemostatic methods for the management of spleen and liver injuries. World J Surg 1996;20:1107-1112.[CrossRef][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Paul Modi
Joseph Rahamim
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Modi, P.
Right arrow Articles by Rahamim, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Modi, P.
Right arrow Articles by Rahamim, J.
Related Collections
Right arrow Esophagus - cancer


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS